The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Evoke Pharma Inc (EVOK)

Evoke Pharma is a pharmaceutical company focused on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Co. is developing Gimoti, an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Diabetic gastroparesis is a GI disorder, in which the stomach takes too long to empty its contents resulting in digestive system symptoms. Metoclopramide is a product approved in the U.S. to treat gastroparesis, and is available only in oral and injection dose forms. Gimoti is a formulation of this drug, designed to provide systemic delivery of metoclopramide through nasal spray administration.

Company Name:  Evoke Pharma Inc
Website:  www.evokepharma.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding EVOK:  2
Total Market Value Held by ETFs:  $227811
Total Market Capitalization:  $59.00M
% of Market Cap. Held by ETFs:  0.39%
October 17, 2017    11:40 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
86th percentile
(ranked higher than approx. 86% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Evoke Pharma Inc (EVOK) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2017, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.